Suboptimal protein intake for hypocaloric diet needs while using glucagon-like peptide-1 receptor agonists
Background The primary aim of this study was to evaluate protein intake of individuals while using a Glucagon-like Peptide-1 Receptor Agonist medication (GLP-1RA). Recommended protein intake during hypocaloric diets is 1.2–2.0 g/kg/d based on adjusted body weight to help preserve muscle mass.Methods...
Saved in:
| Main Authors: | Brittany Johnson, Tyler McGlasson, Olena Thomas, Rachel Kreider, Rachel Jones |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of the International Society of Sports Nutrition |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15502783.2025.2550139 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study
by: Brittany Johnson, et al.
Published: (2025-04-01) -
Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Mechanisms, Efficacy, and Safety
by: Michał Stasiak, et al.
Published: (2025-06-01) -
Glucagon-like peptide 1 receptor agonists in obesity treatment - a literature review
by: Aleksander Jentkiewicz, et al.
Published: (2025-02-01) -
Glucagon-like Peptide-1 Receptor Agonists: A New Frontier in Treating Alcohol Use Disorder
by: Tyler S. Oesterle, et al.
Published: (2025-06-01) -
Diet quality and nutrient distribution while using glucagon-like-peptide-1 receptor agonist: A secondary cross-sectional analysis
by: Brittany V.B. Johnson, et al.
Published: (2025-12-01)